Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?
Sangamo Therapeutics Ownership Summary
Sangamo Therapeutics is owned by 0.14% institutional investors, 1.76% insiders, and 98.10% retail investors. Vanguard group is the largest institutional shareholder, holding 3.94% of SGMO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.51% of its assets in Sangamo Therapeutics shares.
SGMO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sangamo Therapeutics | 0.14% | 1.76% | 98.10% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 12.00M | 3.94% | $5.04M |
| Blackrock | 4.70M | 2.61% | $1.69M |
| Two sigma advisers, lp | 2.11M | 0.82% | $1.42M |
| D. e. shaw | 1.17M | 0.65% | $417.78K |
| Macquarie management | 400.00K | 0.12% | $99.00K |
| Meritage portfolio management | 227.00K | 0.07% | $95.34K |
| Ameriprise financial | 75.27K | 0.04% | $26.97K |
| Hedges asset management | 125.00K | 0.04% | $52.50K |
| Rhumbline advisers | 59.65K | 0.03% | $21.35K |
| Cubist systematic strategies | 54.25K | 0.02% | $36.53K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Hedges asset management | 125.00K | 0.04% | $52.50K |
| Meritage portfolio management | 227.00K | 0.01% | $95.34K |
| Scientech research | 17.02K | 0.00% | $11.46K |
| Two sigma advisers, lp | 2.11M | 0.00% | $1.42M |
| Sandbox financial partners | 24.83K | 0.00% | $6.13K |
| D. e. shaw | 1.17M | 0.00% | $417.78K |
| Flow traders u.s. | 21.50K | 0.00% | $5.00K |
| Macquarie management | 400.00K | 0.00% | $99.00K |
| Cubist systematic strategies | 54.25K | 0.00% | $36.53K |
| Woodline partners lp | 28.86K | 0.00% | $19.43K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma advisers, lp | 2.11M | 0.00% | 901.62K |
| Vanguard group | 12.00M | 0.00% | 385.23K |
| Hedges asset management | 125.00K | 0.04% | 125.00K |
| Ameriprise financial | 75.27K | - | 63.80K |
| Meritage portfolio management | 227.00K | 0.01% | 50.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -40.40M |
| Vanguard capital management | - | - | -12.70M |
| Blackrock | 4.70M | - | -8.57M |
| Two sigma investments, lp | - | - | -6.27M |
| Balyasny asset management | - | - | -5.29M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hedges asset management | 125.00K | 0.04% | 125.00K | $52.50K |
| Flow traders u.s. | 21.50K | 0.00% | 21.50K | $5.00K |
| Scientech research | 17.02K | 0.00% | 17.02K | $11.46K |
| Equitable | 12.85K | - | 12.85K | $5.40K |
| Point72 europe (london) llp | 695.00 | - | 695.00 | $468.00 |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Headlands | -5.00 |
| Us bancorp \de\ | -11.00 |
| Td waterhouse canada | -31.00 |
| Srs capital advisors | -31.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 7 | -94.07% | 533,407 | -99.49% | - | 0.02% | 4 | -93.44% | - | -100.00% |
| Mar 31, 2026 | 102 | -8.11% | 87,227,224 | 40.09% | 25 | 6.17% | 51 | 18.60% | 14 | -58.82% |
| Dec 31, 2025 | 37 | -68.91% | 15,567,844 | -75.13% | 5 | 0.86% | 15 | -72.73% | 8 | -60.00% |
| Sep 30, 2025 | 43 | -61.95% | 19,880,715 | -60.46% | 7 | 2.02% | 17 | -63.83% | 7 | -75.86% |
| Jun 30, 2025 | 118 | -9.92% | 51,227,326 | -2.55% | 19 | 3.50% | 47 | -16.07% | 32 | -5.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 5.65M | 2.51% | 1.00 |
| Wasatch Ultra Growth | 5.59M | 2.28% | 1.06M |
| Vanguard Total Stock Mkt Idx Inv | 7.96M | 1.92% | - |
| SPDR® S&P Biotech ETF | 3.73M | 1.75% | -22.75K |
| Wasatch Micro Cap | 2.34M | 1.12% | -3.31M |
| Vanguard Institutional Extnd Mkt Idx Tr | 4.46M | 1.08% | - |
| Vanguard Strategic Small-Cap Equity Inv | 1.71M | 0.82% | - |
| Vanguard Explorer Inv | 1.40M | 0.67% | - |
| Fidelity Extended Market Index | 2.10M | 0.51% | -7.66K |
| Schwab US Small-Cap ETF™ | 1.80M | 0.43% | -131.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 22, 2026 | Davis Gregory D | Head of Research & Technology | Sell | $17.69K |
| Apr 21, 2026 | Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Sell | $89.18K |
| Sep 26, 2023 | BIOGEN INC. | - | Sell | $3.00M |
| Aug 29, 2022 | BIOGEN INC. | - | Sell | $2.13M |
| Aug 29, 2022 | Biogen MA Inc. | Sell | $526.52K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
SGMO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools